Skip to main content
. 2018 Aug 15;7(8):e11234. doi: 10.2196/11234

Figure 1.

Figure 1

Clinical trial schema for the TheraSphere in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (STOP-HCC) study. TARE: transarterial radioembolization; TS: TheraSphere microspheres.